Key pharmacovigilance stakeholders' experiences of direct patient reporting of adverse drug reactions and their prospects of future development in the European Union-Reference-Cited by-同舟云学术

Key pharmacovigilance stakeholders' experiences of direct patient reporting of adverse drug reactions and their prospects of future development in the European Union

Published:2018-02 Issue: Volume:155 Page:119-128
ISSN:0033-3506
Container-title:Public Health
language:en
Short-container-title:Public Health

Author:

Inácio P.^ORCID,Cavaco A.^ORCID,Allan E.,Airaksinen M.

Publisher

Elsevier BV

Subject

Public Health, Environmental and Occupational Health,General Medicine

Reference41 articles.

1. Adverse drug events in patients admitted to an emergency department: an analysis of direct costs;Meier;Pharmacoepidemiol Drug Saf,2015

2. Epidemiology of adverse drug reactions in Europe: a review of recent observational studies;Bouvy;Drug Saf,2015

3. Promoting and Protecting Public Health: how the European union pharmacovigilance system works;Santoro;Drug Saf,2017

4. The importance of Pharmacovigilance.pdf.

5. Patient-reported safety information: a renaissance of pharmacovigilance?;Harmark;Drug Saf,2016

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and efficacy evaluation of Simo decoction and Arecae semen in herbal medicine practice;Heliyon;2024-06

2. Conducting and interpreting disproportionality analyses derived from spontaneous reporting systems;Frontiers in Drug Safety and Regulation;2024-01-26

3. Knowledge, attitude and practice of pharmacovigilance among Nepalese health professionals;Journal of Pharmacovigilance and Drug Research;2022-09-01

4. The Importance of Direct Patient Reporting of Adverse Drug Reactions in the Safety Monitoring Process;International Journal of Environmental Research and Public Health;2021-12-31

5. Praziquantel and Upper Gastrointestinal Bleeding in Hepatic Schistosomiasis: A Quasi-Experimental Study;Drugs - Real World Outcomes;2020-12-26